Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00327886 · ClinicalTrials.gov registry record

Managing Cyanosis Following Bidirectional Glenn Operation

A clinical trial, sponsored by Children's Healthcare of Atlanta.

Terminated
Registry status
150
Enrollment target

NCT00327886: Clinical Trial study, sponsored by Children's Healthcare of Atlanta.

NCT00327886 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00327886 was terminated before completion, sponsored by Children's Healthcare of Atlanta.

TERMINATED
Registry status
150 participants
Enrollment target

Study Summary

The purpose of this retrospective study is to review the postoperative medical management of infants who underwent bidirectional Glenn operation from January 1, 2003 to December 31, 2005 who were significantly cyanotic.

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2006-02
Est. Completion 2006-02
Children's Healthcare of Atlanta

80 total trials

Why NCT00327886 stopped before completion

NCT00327886 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00327886 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00327886 about?

NCT00327886 is a clinical study titled "Managing Cyanosis Following Bidirectional Glenn Operation". The purpose of this retrospective study is to review the postoperative medical management of infants who underwent bidirectional Glenn operation from January 1, 2003 to December 31, 2005 who were significantly cyanotic.

What is the current status of trial NCT00327886?

This trial is currently terminated. The enrollment target is 150 participants. The study started on 2006-02. Estimated completion is 2006-02.

Who is sponsoring clinical trial NCT00327886?

This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00327886, the US trial registry maintained by the National Library of Medicine. NCT00327886 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.